Recommended the Issuance of Bonus Issue, subject to shareholders approval and any other applicable regulatory and statutory approval, in the ratio of 1:4 .i.e. 1(one) new Fully paid up ....

Titan Biotech Ltd has recommended a bonus issue of shares in the ratio of 1:4, subject to shareholder approval, and also approved the re-appointment of an independent director and an increase in authorized share capital.